Azurity Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on the needs of patients, especially children and the elderly, requiring customized, user-friendly drug formulations. The firm?s products include Epaned, Qbrelis, Xatmep and FIRVANQ oral solutions. The company was founded in 1998 and is headquartered in Woburn, MA.

Hospira was an American global pharmaceutical and medical device company with headquarters in Lake Forest, Illinois. It had approximately 19,000 employees. Before its acquisition by Pfizer, Hospira was the world's largest producer of generic injectable pharmaceuticals, manufacturing generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems. Hospira's products are used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. It was formerly the hospital products division of Abbott Laboratories. On September 3, 2015, Hospira was acquired by Pfizer, who subsequently sold off the medical devices portion of Hospira to ICU Medical.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Zhejiang Puli Pharmaceutical Co., Ltd., established on 2003-08-13, Business scope includes licensed projects:Drug Wholesale;Drug retail;pharmaceutical production;Production of Class II Medical Devices;food production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Import and export;Pharmaceutical special equipment sales;Machinery sales;Metal Material Sales;food sales(Only sell prepackaged food);Chemical product sales(No licensed chemical products);Sales of electronic components and electromechanical components;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Hainan Poly Pharm. Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The firm is specialized in injections and oral solid formulations. Its products include injection, oral solid dosage, dry suspension and active pharmaceutical ingredient (API). The company was founded by Min Hua Fan on July 14, 1992 and is headquartered in Haikou, China.

Zhejiang Pharmaceutical Co., Ltd. Xinchang Pharmaceutical Factory, established on 1999-02-13, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;food production;food business;Hazardous Chemical Production;Food additive production;Feed additive production;road freight transport(Does not contain dangerous goods);road freight transport(Contains dangerous goods)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Feed Additive Sales;Chemical product sales(No licensed chemical products)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).(Engage in business activities within the business scope of the head office)

Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China.

Livzon Group Xinbeijiang Pharmaceutical Manufacturing, Inc. engages in the manufacture of pharmaceutical intermediates, chemical raw materials, and additives. It also involves in research and development, and technical services. The company was founded on March 28, 1993 and is headquartered in Qingyuan, China.

Tianjin Ringpu Bio Technology they develop and produce bio- pharmaceutical products for veterinary medicines and vaccines. They are manufacturer and service provider of animal health products.

Zhejiang Medicine Co., Ltd. engages in the production and sale of pharmaceutical products. It offers anti-infective drugs, glucosidase inhibitors, immunosuppressant, human nutrition, and animal nutrition drugs. The company was founded on May 16, 1997 and is headquartered in Shaoxing, China.

Beijing Changyou Biotechnology Co., Ltd., established on 2021-01-26, Business scope includes technology development;technical consulting;technology transfer;Technology Promotion;Technical Services;software service;software development;Basic software service;Application software service;Computer System Services;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

CJ Corporation (Korean: 씨제이㈜) is a South Korean conglomerate holding company headquartered in Seoul. It comprises numerous businesses in various industries of food and food service, pharmaceutics and biotechnology, entertainment and media, home shopping and logistics. CJ Group was originally a branch of Samsung until it separated in the 1990s.

GenoTech Corp. engages in the production, sales of biotechnology related products and in provision of technical and academic services. It operates through the following business areas: Bio, Gene Synthesis, and Genetic Analysis. The Bio business area offers bio-technology based products and services for improvement of human health, disease prevention, diagnosis and treatment. The Gene Synthesis business area provides products used for biotechnology research and development such as oligonucleotides, enzymes, cloning technology kits and others. The Genetic Analysis business area offers genome analytic and genome sequencing services. The company was founded on July 8, 1997 and is headquartered in Daejeon, South Korea.

Ningxia Tairui Pharmaceutical Co. Ltd. manufacture pharmacies and drug for animals. The firm engages in research and development, production and tiamulin fumarate. The company was founded on January 21, 2000 and is headquartered in Yinchuan, China.

Samyang Biopharmaceuticals Corp. wholesales medical supplies and other medicine-related products. The company was founded on November 1, 2011 and is headquartered in Seongnam, South Korea.

Xellia Pharmaceuticals is a specialty pharmaceutical company focused on providing clinically effective anti-infective treatments against serious and often life-threatening infections. With over 100 years of pharmaceutical industry expertise, we are a leading developer, manufacturer and trusted supplier of fermented and semi-synthetic Active Pharmaceutical Ingredients (APIs) and finished dosage forms (FDF), and the world-leading supplier of Vancomycin and Colistimethate Sodium (CMS). Our range of anti-infective treatments combat, most types of bacterial and antibiotic-resistant infections and certain fungal diseases. We have growing sales in more than 70 countries to over 700 customers and are continually developing and expanding our product range to meet new treatment needs and to better service our customers’ requirements. This includes developing new dosage forms using Xellia’s APIs, and if required APIs sourced from our network of suppliers. To complement our dry powder fill and freeze-dried vials for injectable delivery we are also developing innovative proprietary delivery systems and formulations for topical, inhaled or injectable administration either in house or through partnerships. We also offer contract manufacturing services and custom synthesis for clinical trial material supply. Xellia is a private company, with more than 850 employees and four state-of-the-art manufacturing facilities in Norway, Denmark, Hungary and China. We operate according to current Good Manufacturing Practice (cGMP) and our facilities have received regulatory approval from all relevant authorities, including the US Food and Drug Administration (FDA). Our operational headquarters are in Copenhagen, Denmark.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

North China Pharmaceutical Huasheng Co., Ltd. is a company headquartered in China. The firm manufactures and exports pharmaceutical raw materials.